Company: Cipla Ltd. Category: Result Analysis

Cipla had reported a net profit of Rs 408.8 crore for the corresponding quarter a year ago.
Aug. 9, 2018, 10:42 a.m.

Cipla’s 1QFY19 revenues (Rs39,390mn) and net earnings (Rs4,510mn) were above consensus estimates led by an one-time extraordinary contingent payment of Rs 850mn (Chase Pharma Divestment) reported as other income.
Aug. 9, 2018, 10:22 a.m.

Cipla’s adj Sales, adj. EBITDA and PAT of Rs38.5bn, Rs6.3bn and Rs4.5bn were below our estimates by 7%, 21% and 3% respectively.
Aug. 8, 2018, 10:40 a.m.

Cipla: 4QFY18 Result Update
May 23, 2018, 2:14 p.m.

Cipla : 4QFY18 Result Update
May 23, 2018, 2:10 p.m.

EBITDA and adj. PAT of Rs34.9bn, Rs3.5bn and Rs2.3bn and way below our estimates by 6%, 51% and 25% respectively.
May 23, 2018, 12:10 p.m.

Watch: Cipla posts Q4 profit of Rs 179 crore
May 22, 2018, 5:07 p.m.

Net Sales and PAT of the company are expected to grow at a CAGR of 8% and 6% over 2016 to 2019E respectively.Hence, we say that, we are Overweight in this particular scrip for Medium to Long term investment.
April 18, 2018, 1:43 p.m.

At CMP, stock trades at PE multiples of 21.6x and 18.3x of FY19E and FY20E EPS, respectively, which appear to be expensive. Rolling over our estimates to FY20E, we maintain our HOLD recommendation on the stock with a revised Target Price of Rs675 (from Rs620 earlier).
Feb. 9, 2018, 12:50 p.m.

Cipla: 3QFY18 Result Update
Feb. 8, 2018, 10:09 a.m.
Author : Nirmal Bang | Publisher: